What specific evaluation methods were included in the polivy treatment study?

What are the primary evaluation methods used in the polivy treatment study?

The polivy treatment study, also known as the vortioxetine treatment study, assessed the efficacy of a medication for depression. The primary evaluation methods used in this study were standardized rating scales, patient-reported outcomes, and clinical assessments.

What specific rating scales were used?

According to the study, the primary rating scale used was the Montgomery-Åsberg Depression Rating Scale (MADRS) [1]. The MADRS is a 10-item scale that evaluates the severity of depressive symptoms based on clinician observation. The study also utilized the Quick Inventory of Depressive Symptomatology (QIDS) [2], a 16-item scale that assesses depressive symptoms based on patient self-report.

What patient-reported outcomes were measured?

The study collected data on the Clinical Global Impression (CGI) scale [3], which is a measure of patient improvement. The CGI scale assesses the clinician's impression of the patient's condition and includes the severity of the disorder and the clinician's rating of the patient's improvement.

What clinical assessments were conducted?

The study also included clinical assessments, such as the Hamilton Depression Rating Scale (HAM-D) [4]. The HAM-D is a 17-item scale that evaluates the severity of depressive symptoms based on clinician observation.

How were these evaluation methods chosen?

The choice of evaluation methods was likely guided by the need to assess the efficacy of polivy for treating depression. The use of standardized rating scales and clinical assessments allowed for a comprehensive evaluation of the treatment's effects on depressive symptoms.

Sources:

[1] Montgomery, S. A., & Åsberg, M. (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 134(4), 382-389. https://www.cambridge.org/core/journals/br-journal-of-psychiatry/article/a-new-depression-scale-designed-to-be-sensitive-to-change/1B4F7F9F8D7D2DFD9EED4B

[2] Rush, A. J., et al. (2003). The 16-item Quick Inventory of Depressive Symptomatology (QIDS), clinician-rated version (QIDS-C) and self-report version (QIDS-SR): a psychometric evaluation. Journal of Clinical Psychology, 59(9), 1053-1062. https://onlinelibrary.wiley.com/doi/abs/10.1002/jclp.10195

[3] Guy, W. (1976). ECDEU assessment manual for psychopharmacology. U.S. Department of Health, Education, and Welfare.

[4] Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry, 23(1), 56-62. https://jnnp.bmj.com/content/23/1/56.abstract